Intuitive Surgical, Inc. (LON:0R29)

Market Cap	132.67B -21.2%
Revenue (ttm)	7.48B +20.5%
Net Income	2.12B +23.0%
EPS	5.85 +22.6%
Shares Out	n/a
PE Ratio	62.52
Forward PE	49.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,695
Average Volume	2,334
Open	500.35
Previous Close	499.73
Day's Range	495.05 - 505.50
52-Week Range	406.50 - 608.79
Beta	1.66
RSI	45.45
Earnings Date	Apr 14, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 17,021
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD